Aisling Capital III LP, Ten Percent Owner at Loxo Oncology, holds 2.04M shares in Loxo Oncology (Ticker: LOXO), holds 2.98M shares in Agile Therapeutics (Ticker: AGRX), holds 2.83M shares in T2 Biosystems (Ticker: TTOO). Most recently, Aisling Capital III LP Sold ― shares of Loxo Oncology on Jul 12, 2018 for an estimated value of 251.20M.
What is the percentage of profitable transactions made by Aisling Capital III LP?
The percentage of profitable transactions made by Aisling Capital III LP is 31%.
What is the average return per transaction made by Aisling Capital III LP?
The average return per transaction made by Aisling Capital III LP is -0.10%.
What stocks does Aisling Capital III LP hold?
Aisling Capital III LP holds: LOXO, ARAV, AGRX, TTOO, ASXC, DRTX stocks.
What was Aisling Capital III LP’s latest transaction?
Aisling Capital III LP latest transaction was an Informative Sell of $251.20M.
What was Aisling Capital III LP's most profitable transaction?
Aisling Capital III LP’s most profitable transaction was an Informative Buy of LOXO stock on January 12, 2017. The return on the trade was 87.20%.
What is Aisling Capital III LP's role in Loxo Oncology?
Aisling Capital III LP's role in Loxo Oncology is Ten Percent Owner.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.